Suicidality in Pediatric Patients Treated With Antidepressant Drugs | Zendy

Tarek A. Hammad | Zendy; Thomas Laughren | Zendy; Judith A. Racoosin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Suicidality in Pediatric Patients Treated With Antidepressant Drugs

Author(s) -

Tarek A. Hammad,

Thomas Laughren,

Judith A. Racoosin

Publication year - 2006

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.63.3.332

Subject(s) - placebo , suicidal ideation , antidepressant , fluoxetine , clinical trial , medicine , sertraline , major depressive disorder , psychiatry , randomized controlled trial , depression (economics) , relative risk , anxiety , confidence interval , poison control , injury prevention , serotonin , alternative medicine , receptor , environmental health , cognition , macroeconomics , pathology , economics

There has been concern that widely used antidepressant agents might be associated with an increased risk of suicidal ideation and behavior (suicidality) in pediatric patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research